Blockchain Registration Transaction Record

Quantum Genesis AI Clarifies IP Rights and Quantumzyme Relationship

Quantum Genesis AI (QGAI) clarifies its relationship with Quantumzyme LLP and reaffirms ownership of enzyme engineering IP. Learn about the Asset Purchase Agreement and research affiliations.

This clarification matters because it directly affects investor confidence and the company's credibility. By distinguishing itself from Quantumzyme LLP, Quantum Genesis AI aims to prevent misunderstandings about its intellectual property ownership and research affiliations. Investors and stakeholders rely on accurate disclosures to assess the company's value and technological assets. The clarification reinforces the company's control over critical enzyme engineering and biocatalysis technologies, which are central to its business model. Without this statement, confusion could lead to misinformed investment decisions or legal disputes over IP rights.